Artiva Biotherapeutics (ARTV) Equity Ratio (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Equity Ratio for 3 consecutive years, with 0.84 as the latest value for Q4 2025.
- For Q4 2025, Equity Ratio fell 5.69% year-over-year to 0.84; the TTM value through Dec 2025 reached 0.84, down 5.69%, while the annual FY2025 figure was 0.84, 5.69% down from the prior year.
- Equity Ratio hit 0.84 in Q4 2025 for Artiva Biotherapeutics, down from 0.87 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.89 in Q3 2024 and bottomed at 2.52 in Q2 2024.
- Average Equity Ratio over 3 years is 0.15, with a median of 0.87 recorded in 2025.
- Year-over-year, Equity Ratio soared 157.78% in 2024 and then dropped 5.69% in 2025.
- Artiva Biotherapeutics' Equity Ratio stood at 1.54 in 2023, then soared by 157.78% to 0.89 in 2024, then decreased by 5.69% to 0.84 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods came in at 0.84, 0.87, and 0.88 for Q4 2025, Q3 2025, and Q2 2025 respectively.